PiR News & Press Releases
PiR Group and Heritage Partners International (HPI), announce agreement to work in partnership.
"Executive Search across the Pond"
Cambridge UK, Friday 5th March 2010, PiR Group and Heritage Partners International (HPI), announce agreement to work in partnership.
PiR Group will represent Heritage Partners International in the UK and Ireland and Heritage Partners International will represent PiR Group in the US and Canada for executive search services.
Maurice Herring, Managing Director, PiR Group commented, “We are delighted to be working in partnership with HPI, one of the leading senior executive search firms specialising in life sciences in North America. Heritage Partners International operates from four US locations and their Senior Consultancy team provides vast experience across all life science sectors. This agreement extends PiR’s international reach across North America and strengthens our capability to offer clients a comprehensive service with leading experts at their side. PiR Group’s European, North American and Asian clients will benefit from the combined experience and geographic coverage provided by this agreement”
Kevin Butler, Managing Partner, Heritage Partners International commented, “We are excited to be working in partnership with PiR Group, experts in life science executive search amassed over the last 20 years. HPI will have the opportunity to offer North American clients access to senior level executive search in the UK and Ireland, particularly helpful for companies looking to establish or strengthen their European Headquarters in this part of Europe.
-ENDS-
Notes for editors:
For media enquiries, please contact Maurice Herring on +44 (0)1480 309010 or visit the PiR Group at www.pir-group.com
About Heritage Partners International:
Heritage Partners International (HPI) is a senior level executive search and consulting firm that focuses on delivering superior work to a select group of clients globally in the life sciences industry.
The firm was founded in 2004 by several senior consultants who had previously held leadership positions with the large, general practice firms including Heidrick & Struggles, Spencer Stuart and Russell Reynolds. In addition, our partners have held senior positions at leading pharmaceutical and biotechnology companies in the United States and Europe.
HPI focuses on senior management positions with the life sciences industry:
- CEO’s, COO’s, General Managers and Members of the Board of Directors
- Finance, Business Development, Marketing, Sales and key staff positions
- Regulatory, QA/QC, Manufacturing
- Chief Scientific and Chief Medical Officers, Heads of Discovery and Clinical Development, Medical Affairs.
Our clients include:
- Several top ten pharmaceutical, “specialty” pharmaceutical and biotech companies
- Diagnostic, device and pharmaceutical service companies
- The portfolio companies of select life sciences venture funds.
About PiR Group:
PiR Group is an international life sciences consultancy providing bespoke personalised executive search services to selected clients in each of the life science sectors served across Europe, North America and Asia.
The firm was founded in 1990 by two seasoned industry professionals with expertise in Business Leadership, Human Resources and Talent Acquisition. Over the last 20 years they have continued to grow their knowledge, expertise and range of services in the life sciences industry.
PiR Group is focused on senior and board-level professionals in global markets including:
- Chief Executive Officers, Chief Operations Officers; Senior Vice Presidents, Directors, Vice Presidents, Business Leaders, Consultants, Interim Managers and Independent Directors (Non-Executives)
- Chief Medical Officers; Chief Scientific Officers; Medical Directors, Regulatory Directors; Operations Directors; Quality Directors; Sales & Marketing Directors; Business Development Directors; Country Managers, Business Unit Leaders.
Our clients include:
- Several of the world’s largest life science and pharma organisations, high-growth, medium-sized speciality and emerging biopharma companies
- CMOs, CROs, medical device, diagnostic and scientific equipment and tools suppliers.